Chronic Myeloid Leukemia

Show Only Open Trials

A Phase 3 Randomized, Open-Label Study of Ponatinib versus Imatinib in Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

  • Study Status: Closed to Enrollment
  • Sponsor: Ariad
  • Disease Status and/or Stage: Newly Diagnosed Chronic Myeloid Leukemia
  • Protocol ID: AP24534-12-301

A Prospective Study of Optimally Matched-IPA Targeted Haplo-cord Transplantation

  • Study Status: Open to Enrollment
  • Sponsor: Weill Cornell Medical College
  • Disease Status and/or Stage: Hematologic Malignancies in Need of Donor Stem Cell Transplant

Top of page